These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
665 related articles for article (PubMed ID: 25686167)
1. An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. DeFilippis AP; Young R; Carrubba CJ; McEvoy JW; Budoff MJ; Blumenthal RS; Kronmal RA; McClelland RL; Nasir K; Blaha MJ Ann Intern Med; 2015 Feb; 162(4):266-75. PubMed ID: 25686167 [TBL] [Abstract][Full Text] [Related]
2. Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort. DeFilippis AP; Young R; McEvoy JW; Michos ED; Sandfort V; Kronmal RA; McClelland RL; Blaha MJ Eur Heart J; 2017 Feb; 38(8):598-608. PubMed ID: 27436865 [TBL] [Abstract][Full Text] [Related]
3. Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). Nasir K; Bittencourt MS; Blaha MJ; Blankstein R; Agatson AS; Rivera JJ; Miedema MD; Sibley CT; Shaw LJ; Blumenthal RS; Budoff MJ; Krumholz HM J Am Coll Cardiol; 2015 Oct; 66(15):1657-68. PubMed ID: 26449135 [TBL] [Abstract][Full Text] [Related]
4. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population. Rana JS; Tabada GH; Solomon MD; Lo JC; Jaffe MG; Sung SH; Ballantyne CM; Go AS J Am Coll Cardiol; 2016 May; 67(18):2118-2130. PubMed ID: 27151343 [TBL] [Abstract][Full Text] [Related]
5. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960 [TBL] [Abstract][Full Text] [Related]
6. Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA). Yeboah J; Sillau S; Delaney JC; Blaha MJ; Michos ED; Young R; Qureshi WT; McClelland R; Burke GL; Psaty BM; Herrington DM Am Heart J; 2015 Mar; 169(3):387-395.e3. PubMed ID: 25728729 [TBL] [Abstract][Full Text] [Related]
7. Coronary Artery Calcium for Personalized Allocation of Aspirin in Primary Prevention of Cardiovascular Disease in 2019: The MESA Study (Multi-Ethnic Study of Atherosclerosis). Cainzos-Achirica M; Miedema MD; McEvoy JW; Al Rifai M; Greenland P; Dardari Z; Budoff M; Blumenthal RS; Yeboah J; Duprez DA; Mortensen MB; Dzaye O; Hong J; Nasir K; Blaha MJ Circulation; 2020 May; 141(19):1541-1553. PubMed ID: 32233663 [TBL] [Abstract][Full Text] [Related]
8. ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study. Mortensen MB; Nordestgaard BG; Afzal S; Falk E Eur Heart J; 2017 Feb; 38(8):586-594. PubMed ID: 28363217 [TBL] [Abstract][Full Text] [Related]
9. Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). Miedema MD; Dardari ZA; Kianoush S; Virani SS; Yeboah J; Knickelbine T; Sandfort V; Rodriguez CJ; Nasir K; Blaha MJ J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29899017 [TBL] [Abstract][Full Text] [Related]
10. Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat. Mortensen MB; Nordestgaard BG JAMA Cardiol; 2019 Nov; 4(11):1131-1138. PubMed ID: 31577339 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease. Delabays B; de La Harpe R; Vollenweider P; Fournier S; Müller O; Strambo D; Graham I; Visseren FLJ; Nanchen D; Marques-Vidal P; Vaucher J Eur J Prev Cardiol; 2023 Nov; 30(17):1856-1864. PubMed ID: 37290056 [TBL] [Abstract][Full Text] [Related]
12. Guideline-based statin/lipid-lowering therapy eligibility for primary prevention and accuracy of coronary artery calcium and clinical cardiovascular events: The Multi-Ethnic Study of Atherosclerosis (MESA). Flueckiger P; Qureshi W; Michos ED; Blaha M; Burke G; Sandfort V; Herrington D; Yeboah J Clin Cardiol; 2017 Mar; 40(3):163-169. PubMed ID: 27859433 [TBL] [Abstract][Full Text] [Related]
13. A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study. Mortensen MB; Fuster V; Muntendam P; Mehran R; Baber U; Sartori S; Falk E J Am Coll Cardiol; 2016 Aug; 68(9):881-91. PubMed ID: 27561760 [TBL] [Abstract][Full Text] [Related]
14. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines. Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808 [TBL] [Abstract][Full Text] [Related]
15. Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy. Mortensen MB; Afzal S; Nordestgaard BG; Falk E J Am Coll Cardiol; 2015 Dec; 66(24):2699-2709. PubMed ID: 26700832 [TBL] [Abstract][Full Text] [Related]
16. A 10- and 15-year performance analysis of ESC/EAS and ACC/AHA cardiovascular risk scores in a Southern European cohort. Santos-Ferreira C; Baptista R; Oliveira-Santos M; Moura JP; Gonçalves L BMC Cardiovasc Disord; 2020 Jun; 20(1):301. PubMed ID: 32560700 [TBL] [Abstract][Full Text] [Related]
17. The 2013 ACC/AHA 10-year atherosclerotic cardiovascular disease risk index is better than SCORE and QRisk II in rheumatoid arthritis: is it enough? Ozen G; Sunbul M; Atagunduz P; Direskeneli H; Tigen K; Inanc N Rheumatology (Oxford); 2016 Mar; 55(3):513-22. PubMed ID: 26472565 [TBL] [Abstract][Full Text] [Related]
18. Projected Changes in Statin and Antihypertensive Therapy Eligibility With the AHA PREVENT Cardiovascular Risk Equations. Diao JA; Shi I; Murthy VL; Buckley TA; Patel CJ; Pierson E; Yeh RW; Kazi DS; Wadhera RK; Manrai AK JAMA; 2024 Sep; 332(12):989-1000. PubMed ID: 39073797 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Three Atherosclerotic Cardiovascular Disease Risk Scores With and Without Coronary Calcium for Predicting Revascularization and Major Adverse Coronary Events in Symptomatic Patients Undergoing Positron Emission Tomography-Stress Testing. Anderson JL; Le VT; Min DB; Biswas S; Minder CM; McCubrey RO; Knight S; Horne BD; Mason S; Lappe DL; Muhlestein JB; Knowlton KU Am J Cardiol; 2020 Feb; 125(3):341-348. PubMed ID: 31806210 [TBL] [Abstract][Full Text] [Related]
20. Implications of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline in a Modern Primary Prevention Multi-Ethnic Prospective Cohort (Multi-Ethnic Study of Atherosclerosis). German CA; McEvoy JW; Blaha MJ; Bertoni A; Miedema MD; Burke GL; Yeboah J Am J Cardiol; 2019 Apr; 123(7):1076-1082. PubMed ID: 30654928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]